Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures
Clinical trial NCT00160550 · COMPLETED
Trial details
- NCT number
- NCT00160550
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2005-06-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.